Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Testosterone Cypionate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR known ✓ | P10275 | 5/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.76 |
| ▸ | LMNA | P02545 | 8/20 | 0.76 |
| ▸ | TSHR | P16473 | 5/20 | 0.76 |
| ▸ | MAPT | P10636 | 5/20 | 0.76 |
| ▸ | PGR | P06401 | 5/20 | 0.76 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.76 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.76 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.76 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.76 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.58 |
| ▸ | SHBG | P04278 | 4/20 | 0.58 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.58 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.58 |
| ▸ | SNCA | P37840 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Testosterone Cypionate SCHEMBL6151889 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL1170689 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL16210495 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL18078434 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL26224948 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL5021654 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL12754434 | 1.00 | CYP3A4 (0.76) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL10432170 | 0.99 | CYP3A4 (0.75) | CYP3A4LMNATSHRMAPTPGR | |
| Testosterone Cypionate SCHEMBL5697113 | 0.99 | CYP3A4 (0.75) | CYP3A4LMNATSHRMAPTPGR | |
| SCHEMBL5664755 | 0.99 | CYP3A4 (0.75) | CYP3A4LMNATSHRMAPTPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10388 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085110-A | High-voltage generator stator main insulation aging state assessment method based on trap current | — | 2026-05-26 | — | — | CN | claimed |
| US-12629483-B2 | Syringe shock absorber for use in an injection device | ANTARES PHARMA, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20260125800-A1 | COATING METHOD FOR SEMICONDUCTOR EQUIPMENT | KOMICO LTD (KR) | 2026-05-07 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260034313-A1 | SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE | ANTARES PHARMA, INC. (US) | 2026-02-05 | — | — | US | claimed |
| US-20260034302-A1 | Needle Assisted Injection Device Having Reduced Trigger Force | ANTARES PHARMA, INC. (US) | 2026-02-05 | — | — | US | claimed |
| US-12527802-B2 | Administration of testosterone compositions | ANTARES PHARMA, INC. (US) | 2026-01-20 | — | — | US | claimed |
| US-20260014169-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | AZURITY PHARMACEUTICALS, INC. (US) | 2026-01-15 | — | — | US | claimed |
| WO-2025227129-A2 | DELIVERY VEHICLES COMPRISING PROGLUCAGON DERIVED POLYPEPTIDES AND ANABOLIC POLYPEPTIDES AND USES THEREOF | STARROCK PHARMA LLC (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250325560-A1 | METHODS FOR IMPROVING MUSCLE MASS, STRENGTH, OR FUNCTION WITH A COMBINATION OF TESTOSTERONE AND GROWTH HORMONE | UNIVERSITY OF ROCHESTER (US) | 2025-10-23 | — | — | US | claimed |
| WO-1981001004-A1 | OLIGO SACCHARIDIC FRACTIONS AND OLIGO SACCHARIDES HAVING BIOLOGICAL PROPERTIES,PREPARATION PROCESS THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS | CHOAY SA (FR) | 1981-04-16 | — | — | WO | claimed |
| EP-0022839-A1 | RECUPERATION OF CYANIDES FROM RINSING SOLUTIONS OF CYANIDRIC PROCESSES FOR ELECTRODEPOSITION OF METALS | PEUSER, Michael Franz-Xaver (BR) | 1981-01-28 | — | — | EP | claimed |
| EP-0020661-A1 | PROCESS FOR DESALINATION OF SEA WATER. | SERSEN (FR) | 1981-01-07 | — | — | EP | claimed |
| EP-0020600-A1 | PROCESS FOR FEEDING A SHREDDER WITH PULP SUPPLIED IN BALES. | BEGHIN SAY SA (FR) | 1981-01-07 | — | — | EP | claimed |
| WO-1980002818-A1 | CARBON COMPOSITE ARTICLE AND METHOD OF MAKING SAME | GOODRICH CO B F (US) | 1980-12-24 | — | — | WO | claimed |
| WO-1980001563-A1 | RECUPERATION OF CYANIDES FROM RISING SOLUTIONS OF CYANIDRIC PROCESSES FOR ELECTRODEPOSITION OF METALS | PEUSER M (BR) | 1980-08-07 | — | — | WO | claimed |
| WO-1980001290-A1 | SUPPLY PROCESS OF A DISINTEGRATOR | BEGHIN SAY SA (FR) | 1980-06-26 | — | — | WO | claimed |
| WO-1980001161-A1 | PROCESS FOR DESALINATION OF SEA WATER | EN NOUVELLES SOC ET (FR) | 1980-06-12 | — | — | WO | claimed |
| EP-0006940-A1 | THE PRODUCTION OF ELECTROLYTIC MANGANESE DIOXIDE | Diamond Shamrock Technologies S.A. (CH) | 1980-01-23 | — | — | EP | claimed |
| WO-1979000258-A1 | THE PRODUCTION OF ELECTROLYTIC MANGANESE DIOXIDE | DIAMOND SHAMROCK TECHN (CH) | 1979-05-17 | — | — | WO | claimed |